242 related articles for article (PubMed ID: 17915112)
1. [Effects of viral infection on transplant recipients].
Castón JJ; Cisneros JM; Torre-Cisneros J
Enferm Infecc Microbiol Clin; 2007 Oct; 25(8):535-48. PubMed ID: 17915112
[TBL] [Abstract][Full Text] [Related]
2. [Role of viral infections in immunosuppressed patients].
Salavert M; Granada R; Díaz A; Zaragoza R
Med Intensiva; 2011 Mar; 35(2):117-25. PubMed ID: 21324552
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
4. Viral infections in transplant recipients.
Razonable RR; Eid AJ
Minerva Med; 2009 Dec; 100(6):479-501. PubMed ID: 20010483
[TBL] [Abstract][Full Text] [Related]
5. Indirect effects of cytomegalovirus infection in solid organ transplant recipients.
Pérez-Sola MJ; Castón JJ; Solana R; Rivero A; Torre-Cisneros J
Enferm Infecc Microbiol Clin; 2008 Jan; 26(1):38-47. PubMed ID: 18208765
[TBL] [Abstract][Full Text] [Related]
6. Viral infection after renal transplantation: surveillance and management.
Weikert BC; Blumberg EA
Clin J Am Soc Nephrol; 2008 Mar; 3 Suppl 2(Suppl 2):S76-86. PubMed ID: 18309006
[TBL] [Abstract][Full Text] [Related]
7. CMV infection, diagnosis and antiviral strategies after liver transplantation.
Lautenschlager I
Transpl Int; 2009 Nov; 22(11):1031-40. PubMed ID: 19619175
[TBL] [Abstract][Full Text] [Related]
8. Viral infection in the renal transplant recipient.
Kotton CN; Fishman JA
J Am Soc Nephrol; 2005 Jun; 16(6):1758-74. PubMed ID: 15829710
[TBL] [Abstract][Full Text] [Related]
9. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J
Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
12. Viral infections in lung transplant recipients.
Shah PD; McDyer JF
Semin Respir Crit Care Med; 2010 Apr; 31(2):243-54. PubMed ID: 20354936
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of post-transplant viral infections.
Sun HY; Singh N
Expert Opin Pharmacother; 2008 Oct; 9(14):2409-21. PubMed ID: 18778180
[TBL] [Abstract][Full Text] [Related]
14. Viral infection in renal transplant recipients.
Cukuranovic J; Ugrenovic S; Jovanovic I; Visnjic M; Stefanovic V
ScientificWorldJournal; 2012; 2012():820621. PubMed ID: 22654630
[TBL] [Abstract][Full Text] [Related]
15. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
Mentzer SJ; Perrine SP; Faller DV
Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
[TBL] [Abstract][Full Text] [Related]
16. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
17. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
18. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
Kogan-Liberman D; Burroughs M; Emre S; Moscona A; Shneider BL
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
